Quarter Period Consolidated Statement Of Income

KYORIN Pharmaceutical Co., Ltd. - Filing #7710952

Concept 2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2018-04-01 to
2019-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
2017-04-01 to
2018-03-31
Quarter period consolidated statement of income
Statement of income
Net sales
113,633,000,000 JPY
-13,000,000 JPY
107,872,000,000 JPY
5,761,000,000 JPY
113,620,000,000 JPY
104,718,000,000 JPY
5,937,000,000 JPY
110,655,000,000 JPY
110,640,000,000 JPY
-14,000,000 JPY
Cost of sales
56,210,000,000 JPY
49,064,000,000 JPY
Gross profit (loss)
57,409,000,000 JPY
61,576,000,000 JPY
Selling, general and administrative expenses
Advertising expenses
103,000,000 JPY
2,255,000,000 JPY
300,000,000 JPY
2,653,000,000 JPY
Remuneration for directors (and other officers)
331,000,000 JPY
336,000,000 JPY
Depreciation
249,000,000 JPY
306,000,000 JPY
Selling, general and administrative expenses
48,436,000,000 JPY
52,753,000,000 JPY
Operating profit (loss)
8,515,000,000 JPY
457,000,000 JPY
5,364,000,000 JPY
8,316,000,000 JPY
199,000,000 JPY
8,972,000,000 JPY
8,260,000,000 JPY
187,000,000 JPY
8,447,000,000 JPY
4,624,000,000 JPY
8,822,000,000 JPY
375,000,000 JPY
Non-operating income
Interest income
32,000,000 JPY
28,000,000 JPY
Dividend income
382,000,000 JPY
370,000,000 JPY
Share of profit of entities accounted for using equity method
36,000,000 JPY
28,000,000 JPY
Non-operating income
109,000,000 JPY
798,000,000 JPY
109,000,000 JPY
640,000,000 JPY
Non-operating expenses
Interest expenses
64,000,000 JPY
24,000,000 JPY
Non-operating expenses
358,000,000 JPY
332,000,000 JPY
JPY
118,000,000 JPY
Ordinary profit (loss)
5,115,000,000 JPY
9,438,000,000 JPY
4,734,000,000 JPY
9,345,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
14,000,000 JPY
50,000,000 JPY
Extraordinary income
JPY
66,000,000 JPY
710,000,000 JPY
627,000,000 JPY
Extraordinary losses
Extraordinary losses
1,000,000 JPY
145,000,000 JPY
429,000,000 JPY
910,000,000 JPY
Profit (loss) before income taxes
5,114,000,000 JPY
9,359,000,000 JPY
5,015,000,000 JPY
9,061,000,000 JPY
Income taxes - current
23,000,000 JPY
2,004,000,000 JPY
95,000,000 JPY
2,759,000,000 JPY
Income taxes - deferred
13,000,000 JPY
485,000,000 JPY
255,000,000 JPY
-272,000,000 JPY
Income taxes
37,000,000 JPY
2,490,000,000 JPY
351,000,000 JPY
2,486,000,000 JPY
Profit (loss)
5,076,000,000 JPY
5,076,000,000 JPY
5,076,000,000 JPY
6,869,000,000 JPY
5,076,000,000 JPY
4,663,000,000 JPY
4,663,000,000 JPY
4,663,000,000 JPY
6,574,000,000 JPY
4,663,000,000 JPY
Profit attributable to
Profit (loss) attributable to owners of parent
6,869,000,000 JPY
6,869,000,000 JPY
6,869,000,000 JPY
6,574,000,000 JPY
6,574,000,000 JPY
6,574,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-1,169,000,000 JPY
2,456,000,000 JPY
Foreign currency translation adjustment
-27,000,000 JPY
-31,000,000 JPY
Remeasurements of defined benefit plans, net of tax
46,000,000 JPY
133,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-6,000,000 JPY
0 JPY
Other comprehensive income
-1,157,000,000 JPY
2,557,000,000 JPY
Comprehensive income
5,711,000,000 JPY
9,132,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
5,711,000,000 JPY
9,132,000,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.